In esophageal squamous cell carcinoma, PD-L1 expression can also be increased by chemotherapeutic treatments through activating the EGFR/ERK signaling pathway (Ng et al., 2018). The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.